Moreover, tumor cells that have KRAS/TP53 mutations, are forced to survive on Asn recycled from protein degradation in the proteasome as autophagy is inhibited and not available as an alternative protein recycling pathway (Hinze et al., 2020). This evidence concerns the gene KRAS and neoplasm.